| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Luo,Chang-Geng | Chairman | 15.60% | Agpharma International Ltd. |
| Su Zhang,He-Hui | Director | 15.60% | Agpharma International Ltd. |
| Liao,Zhi-Yang | Director | 2.32% | |
| Ji,Yue-E | Director | 0.00% | |
| Zheng,Qin-Hua | Independent Director | 0.00% | |
| Xue,Rong | Independent Director | 0.00% | |
| Lin,Ming-De | Independent Director | 0.00% |
Change Company Name to ChongDah Health Co., Ltd.
2023/11/07
Change Company Name to ZHONGDA BIOMEDICAL CO., LTD. (FORMER NAME: ZHONGDA HEALTH INVESTMENT HOLDINGS CO., LTD.)
2022/05/30
Change Company Name to ChongDah Health Co., Ltd.
2019/08/19
Change Company Name to ZHONG DA JIAN YE INVESTMENT HOLDINGS CO., LTD.
2017/12/19
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 1,367,951 | 2,601,563 | 2,232,839 |
| Operating cost | 972,062 | 1,876,437 | 1,575,920 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 395,889 | 725,126 | 656,919 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 395,889 | 725,126 | 656,919 |
| Operating expenses | 220,309 | 417,297 | 467,365 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 175,580 | 307,829 | 189,554 |
| Non-operating income and expenses | 7,527 | 57,585 | 104,444 |
| Net profit (loss) before tax | 183,107 | 365,414 | 293,998 |
| Income tax expense (benefits) | 42,309 | 87,197 | 75,657 |
| Net profit (loss) of ongoing business for the current period | 140,798 | 278,217 | 218,341 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 140,798 | 278,217 | 218,341 |
| Other comprehensive profit (loss), net | 83,313 | -20,367 | 56,851 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 224,111 | 257,850 | 275,192 |
| Net profit (loss) attributable to owners of parent company | 140,798 | 278,217 | 218,341 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 224,111 | 257,850 | 275,192 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 1 | 3 | 2 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -23,996 | 132,547 | 167,509 |
| Net cash inflows (outflows) from investing activities | -48,700 | 92,517 | -95,306 |
| Net cash inflow (outflow) from financing activities | 139,676 | -287,697 | 125,810 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1,688 | -8,505 | -1,490 |
| Increase (decrease) in cash and cash equivalents in the current period | 68,668 | -71,138 | 196,523 |
| Beginning balance of cash and cash equivalents | 372,087 | 443,225 | 246,702 |
| Ending balance of cash and cash equivalents | 440,755 | 372,087 | 443,225 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 2,277,901 | 2,073,783 | 1,955,794 |
| Non-current asset | 2,761,062 | 2,653,714 | 2,704,907 |
| Total asset | 5,038,963 | 4,727,497 | 4,660,701 |
| Current liability | 1,754,602 | 1,432,872 | 1,513,101 |
| Non-current liability | 614,015 | 649,814 | 701,362 |
| Total liability | 2,368,617 | 2,082,686 | 2,214,463 |
| share capital | 749,359 | 749,359 | 749,359 |
| Equity - secruity token | - | - | - |
| capital reserve | 818,855 | 815,104 | 799,445 |
| retained earning | 1,031,476 | 1,093,005 | 890,512 |
| Other equity | 70,656 | -12,657 | 6,922 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 2,670,346 | 2,644,811 | 2,446,238 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 2,670,346 | 2,644,811 | 2,446,238 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 35 | 35 | 32 |
